Development of Biomarkers for Monitoring Menopause in Women
Recruiting now
Conditions studied: Perimenopausal Biomarkers, Mitochondrial Biomarkers
In brief
This cross-sectional study aims to develop and validate mitochondrial biomarkers for monitoring menopause in women. The study will involve 100 participants divided into three groups: reproductive period, perimenopausal transition period, and postmenopausal period. Peripheral blood samples will be collected, and mitochondrial quality and quantity will be assessed using both qualitative and quantitative analyses. The study will identify potential biomarkers through metabolomics and validate them for monitoring the perimenopausal transition, providing a novel approach for women's health management during menopause.
Key facts
- Study ID
- NCT06852755
- Run by
- Fu Jen Catholic University Hospital
- People needed
- 100
- Starts
- 2024-07-30
- Expected to finish
- 2026-08-01
- Last updated by the study team
- 2025-05-25
Who can join
Age: 20 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Biological female, age order than 20 years old.
You may not qualify if…
- Person with cancer.
- Person with any known acute or chronic infection.
- Person with known chronic illness under follow up or treatment.
- Pregnancy, one year withing delivery, under breast feeding, or three months within breast feeding.
- Under any female horemone therapy.
Where it is running
- Fu Jen Catholic University Hospital, Fu Jen Catholic University — New Taipei City, Taiwan (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.